Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 7;3(1):53-72.
doi: 10.3390/pharmaceutics3010053.

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Affiliations

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Eva Fernandez et al. Pharmaceutics. .

Abstract

Many physiologic differences between children and adults may result in age-related changes in pharmacokinetics and pharmacodynamics. Factors such as gastric pH and emptying time, intestinal transit time, immaturity of secretion and activity of bile and pancreatic fluid among other factors determine the oral bioavailability of pediatric and adult populations. Anatomical, physiological and biochemical characteristics in children also affect the bioavailability of other routes of administration. Key factors explaining differences in drug distribution between the pediatric population and adults are membrane permeability, plasma protein binding and total body water. As far as drug metabolism is concerned, important differences have been found in the pediatric population compared with adults both for phase I and phase II metabolic enzymes. Immaturity of glomerular filtration, renal tubular secretion and tubular reabsorption at birth and their maturation determine the different excretion of drugs in the pediatric population compared to adults.

PubMed Disclaimer

References

    1. Morselli P.L., Franco-Morselli R., Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin. Pharmacokinet. 1980;5:485–527. - PubMed
    1. Bartelink I.H., Rademaker C.M., Schobben A.F., van den Anker J.N. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin. Pharmacokinet. 2006;45:1077–1097. - PubMed
    1. Stewart C.F., Hampton E.M. Effect of maturation on drug disposition in pediatric patients. Clin. Pharm. 1987;6:548–564. - PubMed
    1. Strolin Benedetti M., Whomsley R., Baltes E.L. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Expert Opin. Drug Metab. Toxicol. 2005;1:447–471. - PubMed
    1. Brown R.D., Campoli-Richards D.M. Antimicrobial therapy in neonates, infants and children. Clin. Pharmacokinet. 1989;17(Suppl. 1):105–115. - PubMed

LinkOut - more resources